T0	Biomarker 601 617	CC-16 deficiency
T2	Disease 767 771	COPD
T3	Disease 864 868	COPD
T4	Disease 1169 1178	emphysema
#5	AnnotatorNotes T4	D004646
T5	Disease 1264 1300	chronic inflammatory airway diseases
#6	AnnotatorNotes T5	not found
T6	Gene-Protein 1054 1059	CC-16
T7	Gene-Protein 891 896	CC-16
T8	Gene-Protein 30 35	CC-16
#4	AnnotatorNotes T8	HGNC:12523
T10	Gene-Protein 197 202	CC-16
T11	Disease 298 314	oxidative stress
#8	AnnotatorNotes T11	D018384
T12	Biomarker 324 355	Decreased serum levels of CC-16
T13	Biomarker 375 382	smokers
#9	AnnotatorNotes T13	D000074285
T14	Gene-Protein 350 355	CC-16
T15	Disease 480 484	COPD
#10	AnnotatorNotes T15	DOID:3083
T16	Gene-Protein 486 491	CC-16
T17	Gene-Protein 601 606	CC-16
T18	Gene-Protein 702 707	CC-16
T19	Gene-Protein 787 792	CC-16
T20	Disease 628 666	smoking-induced pulmonary inflammation
#3	AnnotatorNotes T20	not found
R1	Association Arg1:T0 Arg2:T20	
T1	Biomarker 702 707	CC-16
T21	Biomarker 725 746	lung function decline
T22	Biomarker 787 792	CC-16
T23	Disease 986 990	COPD
R2	Association Arg1:T22 Arg2:T3	
T24	Biomarker 883 903	reduced CC-16 levels
T25	Biomarker 927 973	accelerated decline in lung function over time
R3	Association Arg1:T24 Arg2:T23	
T26	Biomarker 1054 1069	CC-16 was lower
T27	Biomarker 1087 1120	low FEV₁, DLCO, FVC, and FEV₁/FVC
T28	Drug 197 202	CC-16
#1	AnnotatorNotes T28	C481939
T29	Disease 228 255	inflammation of the airways
#2	AnnotatorNotes T29	not found
R4	Response Arg1:T28 Arg2:T29	
R5	Protects-from Arg1:T28 Arg2:T11	
T9	Biomarker 486 570	CC-16 in bronchoalveolar lavage fluid (BALF) and serum has been reported to be lower
R6	Association Arg1:T9 Arg2:T15	
#7	AnnotatorNotes T1	C481939
T30	Biomarker 1209 1244	increased destruction of club cells
R7	Association Arg1:T30 Arg2:T5	
T31	Biomarker 1306 1337	severely impaired lung function
